Overview
Portfolio
More
BlueYard Capital
BlueYard Capital backs founders at the earliest stages, focusing on technologies that shape the future—AI, blockchain, and deep‑tech life sciences. They target pre‑seed to Series A rounds, investing $0.5‑5 M as lead or c...
Portfolio
68+
Employees
15+
Founded
2016
AUM
≈ $500.0M
Investment focus
Stages
Pre-Seed → Series A
Industries
Software OnlyArtificial IntelligenceBiotechnologyBlockchain & Cryptocurrency
Geographic scope
Global
Fund details
Funds
BlueYard I
Vintage 2016 • $121.0M
BlueYard II
Vintage 2019 • $115.5M
BlueYard III
Vintage 2022 • $185.0M
Check sizes
Min: $500.0K
Typical: $2.5M
Max: $5.0M
Sources
BlueYard Capital
BlueYard Capital backs founders at the earliest stages, focusing on technologies that shape the future—AI, blockchain, and deep‑tech life sciences. They target pre‑seed to Series A rounds, investing $0.5‑5 M as lead or co‑lead to help build foundational infrastructure and transformative products.
Portfolio
68+
Employees
15+
Founded
2016
AUM
≈ $500.0M
Funds
BlueYard I · Vintage 2016 • $121.0M
BlueYard II · Vintage 2019 • $115.5M
BlueYard III · Vintage 2022 • $185.0M
Check Sizes
Min: $500.0K
Typical: $2.5M
Max: $5.0M
Stages
Pre-Seed → Series A
Industries
Software OnlyArtificial IntelligenceBiotechnologyBlockchain & CryptocurrencyHealthcare Technology
Geographic scope
Global
Sources
Showing 24 of 56 matched portfolio companies
Aerska develops next-generation RNA medicines specifically engineered for systemic administration and targeted delivery across the blood-brain barrier. The company leverages precision medicine approaches to silence disease-causing genes within the central nervous system. This focus aims to transform the treatment landscape for debilitating brain diseases by offering potent and durable therapeutic options.
15+
2K+Approximate amount of employees
Funding: $21.0M
Rough estimate of the amount of funding raised
BACKED VCSpeedinvest
BACKED VCSpeedinvest
Funding: $21.0M
Rough estimate of the amount of funding raised
Airtm is a blockchain and bank-connected digital wallet that facilitates peer-to-peer currency exchange, allowing users to convert digital dollars into local currencies through over 500 payment methods. This platform addresses the challenges of accessing stable financial services and transferring funds across borders, enabling users to manage their money securely and efficiently.
Funding: $24.6M
Rough estimate of the amount of funding raised
Stellar Development Foundation
Stellar Development Foundation
Funding: $24.6M
Rough estimate of the amount of funding raised
This company develops advanced RF networking platforms and high-speed DSP frameworks for aerospace and defense applications. Their technology provides unified operations, cross-network interoperability, and adaptive waveform control for mission-critical communications. They deliver multi-band RF systems engineered for extreme conditions supporting satellite constellations and forward-operating bases.
Funding: $14.7M
Rough estimate of the amount of funding raised
Funding: $14.7M
Rough estimate of the amount of funding raised
Biomia utilizes synthetic biology techniques to develop plant-derived natural products aimed at treating unmet medical conditions. The company focuses on creating effective therapeutic solutions that address gaps in current medical treatments.
Funding: $3.2M
Rough estimate of the amount of funding raised
Funding: $3.2M
Rough estimate of the amount of funding raised
Bit.bio develops a cell coding platform that utilizes deterministic programming to create and manufacture any human cell type with precision and scalability. This technology addresses the need for consistent and reliable cell production for research and therapeutic applications, enabling the development of next-generation treatments.
Funding: $214.2M
Rough estimate of the amount of funding raised
Funding: $214.2M
Rough estimate of the amount of funding raised
Castelion designs and manufactures affordable hypersonic weapons systems optimized for cost, manufacturability, and rapid deployment at national security scale. The company vertically integrates core technologies to accelerate the design-to-production timeline for credible, non-nuclear deterrence capabilities. By focusing on high-volume production readiness, Castelion restores the ability to out-innovate and out-produce strategic rivals.
Funding: $70.0M
Rough estimate of the amount of funding raised
Lightspeed Venture Partners
Lightspeed Venture Partners
Funding: $70.0M
Rough estimate of the amount of funding raised
The startup has developed a decentralized operating system that enables third-party service providers to create and interact with data in the financial supply chain. This system allows businesses to transact globally while retaining ownership of their validated company information and transaction history.
Funding: $30.8M
Rough estimate of the amount of funding raised
GreenfieldParaFi Capital
GreenfieldParaFi Capital
Funding: $30.8M
Rough estimate of the amount of funding raised
Chemify is a platform that digitizes chemistry and chemical discovery by executing chemical code for drug discovery, synthesis, and materials development. This technology accelerates the synthesis of complex molecules and enables the creation of extensive functional libraries, enhancing reproducibility and efficiency in molecular optimization.
Funding: $57.1M
Rough estimate of the amount of funding raised
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
Funding: $57.1M
Rough estimate of the amount of funding raised
clock.bio develops a platform to decode the rejuvenation genome and validate interventions that reverse cellular aging. The company integrates proprietary technologies, including the geneAge Atlas and AI-driven imAge measurement, for high-throughput target discovery and measurement. This systematic approach aims to translate rejuvenation biology into topical, nutraceutical, and systemic therapeutics to extend human healthspan.
Funding: $10.0M
Rough estimate of the amount of funding raised
LocalGlobe
LocalGlobe
Funding: $10.0M
Rough estimate of the amount of funding raised
Corintis designs and mass‑produces microfluidic cold plates and co‑packaged cooling solutions for high‑power AI and HPC chips. Their platform delivers up to 10× better chip cooling with lower flow rates and pressure drops, enabling higher TDP in data‑center and HPC environments. The technology is built for large‑scale production, targeting more efficient thermal management in next‑generation compute workloads.
Funding: $4.6M
Rough estimate of the amount of funding raised
Funding: $4.6M
Rough estimate of the amount of funding raised
This startup is developing a decentralized exchange using the Cosmos SDK and IBC protocol, enabling businesses to build scalable blockchain applications with low transaction fees and high security. By providing a customizable appchain architecture, it addresses the need for efficient and cost-effective solutions in the fragmented blockchain ecosystem.
Founded 2016
CPTx develops in vivo CAR-T and other genetic medicines using an immune-silent single-stranded DNA (ssDNA) platform. This technology leverages precision-engineered ssDNA and non-viral lipid nanoparticle delivery for durable expression and repeat dosing without viral vectors or mRNA. The company aims to make transformative cell therapies more accessible, affordable, and scalable for patients with cancer.
Funding: $29.0M
Rough estimate of the amount of funding raised
BlueYard CapitalSPRIN-D
BlueYard CapitalSPRIN-D
Funding: $29.0M
Rough estimate of the amount of funding raised
Creasallis develops CreaTap, a patented, plug-and-play technology that modifies antibody therapeutics to enhance their penetration into solid tumours. This engineering solution addresses the limitation of poor drug diffusion within the tumour microenvironment for monoclonal antibodies, ADCs, and bispecifics. The technology aims to improve therapeutic efficacy by enabling deeper drug delivery and potentially creating new intellectual property opportunities for existing biologics.
Funding: $980.0K
Rough estimate of the amount of funding raised
Funding: $980.0K
Rough estimate of the amount of funding raised
Provides enterprise-grade accounting and tax software for digital assets, automating GAAP and IFRS compliant reporting through blockchain data reconciliation and internal controls. This platform ensures auditable financial records by integrating with wallets, exchanges, and custodians to track, categorize, and reconcile on-chain activities with internal systems, enabling businesses to meet regulatory requirements and streamline audit processes.
Funding: $24.5M
Rough estimate of the amount of funding raised
Point Nine
Point Nine
Funding: $24.5M
Rough estimate of the amount of funding raised
Cytosolix develops oral and intravenous formulations that specifically target tumor acidity to enhance the effectiveness of small molecule cancer therapies. By addressing the acidic microenvironment of tumors, these derivatives aim to improve therapeutic outcomes for cancer patients.
Funding: $7.0M
Rough estimate of the amount of funding raised
Funding: $7.0M
Rough estimate of the amount of funding raised
DIMO provides a vehicle intelligence platform that enables developers to build connected car applications compatible across various OEMs. The platform normalizes vehicle data streams, offering open APIs and AI-ready context for streamlined development and workflow automation. It supports user-owned data architecture with granular permissions, ensuring privacy and compliance for mobility solutions.
DXOS offers a local‑first framework for real‑time, peer‑to‑peer collaboration that eliminates the need for persistent cloud services. Its open‑source Echo database uses CRDT‑based replication and conflict resolution for secure client‑side storage, while Halo provides cryptographic public‑private key identities for fine‑grained access control, and Mesh extends internet protocols to create resilient, encrypted peer networks. This enables developers to build collaborative, data‑intensive apps that work offline, retain full data ownership, and scale without centralized infrastructure.
ExpressionEdits utilizes its Genetic Syntax Engine, an AI-driven computational platform, to optimize transgene design through intronization. This technology precisely edits genetic grammar to unlock the expression of previously inaccessible proteins for therapeutic applications. The platform enhances gene expression and potency, enabling the development of high-value protein therapeutics and optimizing existing gene therapy constructs.
Funding: $9.5M
Rough estimate of the amount of funding raised
Octopus Venturesredalpine
Octopus Venturesredalpine
Funding: $9.5M
Rough estimate of the amount of funding raised
Develops flat panel antennas with active electronically scanned arrays (AESAs) that enable satellite user terminals to track moving satellites and users, reducing size, weight, power, and cost (SWaP-C). This technology expands satellite internet accessibility, addressing the challenge that only 12% of its potential is currently utilized due to the high cost of existing terminals.
Funding: $13.6M
Rough estimate of the amount of funding raised
Funding: $13.6M
Rough estimate of the amount of funding raised
Filecoin is an open‑source, peer‑to‑peer storage network that turns unused disk capacity into a verifiable marketplace where providers earn FIL tokens for sealing and serving data. Clients store and retrieve content‑addressed files using cryptographic Proof‑of‑Replication and Proof‑of‑Spacetime guarantees, with pricing set by on‑chain supply and demand. The platform integrates IPFS and a programmable Filecoin Virtual Machine for automated storage contracts and escrow.
50+
10K+Approximate amount of employees
Flashbots is a research and development organization that provides tools for transparent and efficient Maximal Extractable Value (MEV) extraction on Ethereum, including the Flashbots Protect service for transaction protection and the MEV-Boost relay for competitive block sourcing. The company addresses the centralization risks and negative externalities of MEV by democratizing access to MEV revenue and ensuring fair transaction execution for users.
Funding: $60.0M
Rough estimate of the amount of funding raised
Paradigm
Paradigm
Funding: $60.0M
Rough estimate of the amount of funding raised
Foresight Data Machines provides an AI‑driven automation platform that ingests real‑time sensor data from production lines, applies machine‑learning models to detect anomalies, predict equipment failures, and continuously optimize process parameters. The solution integrates with existing PLC and SCADA systems via OPC‑UA, MQTT, and REST APIs, offering a unified dashboard with customizable KPIs and edge deployment for low‑latency inference, helping manufacturers improve equipment utilization and reduce downtime without major hardware upgrades.
Funding: $3.8M
Rough estimate of the amount of funding raised
Funding: $3.8M
Rough estimate of the amount of funding raised
Forta provides a real‑time on‑chain firewall that monitors transaction streams, uses AI‑driven simulations to detect and block malicious calls before execution, and screens transactions against sanctions lists. The service integrates without code changes via rollup and infrastructure partners, delivering instant alerts and detailed logs for protocol teams, rollup operators, and DeFi applications.
Funding: $23.0M
Rough estimate of the amount of funding raised
Funding: $23.0M
Rough estimate of the amount of funding raised
FreedomFi builds cost-efficient Private LTE networks using commodity hardware, open-source software, and CBRS shared spectrum to provide reliable connectivity in underserved areas. This technology addresses the lack of affordable and accessible wireless communication infrastructure for businesses and communities.
Funding: $9.5M
Rough estimate of the amount of funding raised
Funding: $9.5M
Rough estimate of the amount of funding raised
Showing 12 of 12 unmatched portfolio companies